Search Results

There are 10256 results for: content related to: Effectiveness of Tadalafil 5 mg Once Daily in the Treatment of Men with Lower Urinary Tract Symptoms Suggestive to Benign Prostatic Hyperplasia With or Without Erectile Dysfunction: Results from Naturalistic Observational T ada L uts E d Study

  1. A Comparative Randomized Prospective Study to Evaluate Efficacy and Safety of Combination of Tamsulosin and Tadalafil vs. Tamsulosin or Tadalafil Alone in Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

    The Journal of Sexual Medicine

    Volume 11, Issue 1, January 2014, Pages: 187–196, Dig Vijay Singh, Uttam Kumar Mete, Arup Kumar Mandal and Shrawan Kumar Singh

    Version of Record online : 24 OCT 2013, DOI: 10.1111/jsm.12357

  2. Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 3, September 2012, Pages: 110–119, Masayuki TAKEDA, Osamu NISHIZAWA, Takeshi IMAOKA, Yoji MORISAKI and Lars VIKTRUP

    Version of Record online : 1 MAR 2012, DOI: 10.1111/j.1757-5672.2012.00144.x

  3. You have free access to this content
    Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study

    BJU International

    Volume 107, Issue 7, April 2011, Pages: 1110–1116, Craig F. Donatucci, Gerald B. Brock, Evan R. Goldfischer, Peter J. Pommerville, Albert Elion-Mboussa, Jay D. Kissel and Lars Viktrup

    Version of Record online : 18 JAN 2011, DOI: 10.1111/j.1464-410X.2010.09687.x

  4. You have free access to this content
    Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction

    BJU International

    Volume 112, Issue 7, November 2013, Pages: 990–997, Gerald Brock, Gregory Broderick, Claus G. Roehrborn, Lei Xu, David Wong and Lars Viktrup

    Version of Record online : 13 AUG 2013, DOI: 10.1111/bju.12251

  5. You have free access to this content
    Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

    International Journal of Urology

    Volume 21, Issue 7, July 2014, Pages: 670–675, Masayuki Takeda, Osamu Yokoyama, Sung Won Lee, Masahiro Murakami, Yoji Morisaki and Lars Viktrup

    Version of Record online : 27 FEB 2014, DOI: 10.1111/iju.12410

  6. You have free access to this content
    Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men

    International Journal of Urology

    Volume 20, Issue 2, February 2013, Pages: 193–201, Osamu Yokoyama, Masaki Yoshida, Sae Chul Kim, Chii-Jye Wang, Takeshi Imaoka, Yoji Morisaki and Lars Viktrup

    Version of Record online : 7 SEP 2012, DOI: 10.1111/j.1442-2042.2012.03130.x

  7. You have free access to this content
    Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study

    BJU International

    Volume 114, Issue 4, October 2014, Pages: 568–575, Matthias Oelke, François Giuliano, Simin K. Baygani, Thomas Melby and Angelina Sontag

    Version of Record online : 24 SEP 2014, DOI: 10.1111/bju.12733

  8. You have free access to this content
    Comparison of efficacy for erectile function and lower urinary tract symptoms of tadalafil 20 mg on-demand and 5 mg once daily in patients with erectile dysfunction

    International Journal of Clinical Practice

    Volume 66, Issue 8, August 2012, Pages: 813–820, D. H. Kang, J. Y. Lee, J. H. Chung, J. M. Cho, S. H. Lee, J. Park, T. H. Kim, T. K. Yoo and S. W. Lee

    Version of Record online : 16 JUL 2012, DOI: 10.1111/j.1742-1241.2012.02946.x

  9. Proceedings of the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Miami Beach, USA, November 20–23, 2014

    The Journal of Sexual Medicine

    Volume 12, Issue S2, May 2015, Pages: 101–183,

    Version of Record online : 9 APR 2015, DOI: 10.1111/jsm.12808

  10. Proceedings of the 16th Annual Congress of the European Society for Sexual Medicine and the 12th Congress of the European Sexology Federation, Istanbul, Turkey, January 29–February 1, 2014

    The Journal of Sexual Medicine

    Volume 11, Issue S1, January 2014, Pages: 1–108,

    Version of Record online : 24 JAN 2014, DOI: 10.1111/jsm.12415

  11. Tadalafil – a therapeutic option in the management of BPH-LUTS

    International Journal of Clinical Practice

    Volume 68, Issue 1, January 2014, Pages: 94–103, C. C. Carson, M. Rosenberg, J. Kissel and D. G. Wong

    Version of Record online : 17 DEC 2013, DOI: 10.1111/ijcp.12305

  12. You have free access to this content
    Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia – integrated data from 1 499 study participants

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 815–821, John Curtis Nickel, Gerald B. Brock, Sender Herschorn, Ruth Dickson, Carsten Henneges and Lars Viktrup

    Version of Record online : 7 MAR 2015, DOI: 10.1111/bju.12926

  13. Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia and on Erectile Dysfunction in Sexually Active Men with Both Conditions: Analyses of Pooled Data from Four Randomized, Placebo-Controlled Tadalafil Clinical Studies

    The Journal of Sexual Medicine

    Volume 10, Issue 8, August 2013, Pages: 2044–2052, Hartmut Porst, Claus G. Roehrborn, Roberta J. Secrest, Anne Esler and Lars Viktrup

    Version of Record online : 19 JUN 2013, DOI: 10.1111/jsm.12212

  14. Randomized Controlled Trial to Assess the Efficacy of the Combination Therapy of Alfuzosin and Tadalafil in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

    LUTS: Lower Urinary Tract Symptoms

    Volume 6, Issue 1, January 2014, Pages: 35–40, Santosh KUMAR, Chilekampalli KONDAREDDY, Raguram GANESAMONI, Bhuvanesh NANJAPPA and Shrawan K. SINGH

    Version of Record online : 3 APR 2013, DOI: 10.1111/luts.12016

  15. Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 6, June 2013, Pages: 639–649, Matthew A. Cantrell, Jordan Baye and Scott Martin Vouri

    Version of Record online : 25 MAR 2013, DOI: 10.1002/phar.1243

  16. Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study

    The Journal of Sexual Medicine

    Volume 9, Issue 1, January 2012, Pages: 271–281, Russell Blair Egerdie, Stephen Auerbach, Claus G. Roehrborn, Pierre Costa, Martin Sanchez Garza, Anne L. Esler, David G. Wong and Roberta J. Secrest

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1743-6109.2011.02504.x

  17. Tadalafil Effect on Metabolic Syndrome-Associated Bladder Alterations: An Experimental Study in a Rabbit Model

    The Journal of Sexual Medicine

    Volume 11, Issue 5, May 2014, Pages: 1159–1172, Linda Vignozzi, Sandra Filippi, Paolo Comeglio, Ilaria Cellai, Annamaria Morelli, Elena Maneschi, Erica Sarchielli, Mauro Gacci, Marco Carini, Gabriella Barbara Vannelli and Mario Maggi

    Version of Record online : 26 FEB 2014, DOI: 10.1111/jsm.12478

  18. Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo-Controlled Pilot Study Using Tamsulosin as an Active Control

    LUTS: Lower Urinary Tract Symptoms

    Volume 3, Issue 2, September 2011, Pages: 86–93, Sae Chul KIM, Jong Kwan PARK, Sae Woong KIM, Sung Won LEE, Tai Young AHN, Je Jong KIM, Jae Seung PAICK, Nam Cheol PARK, Kwangsung PARK, Kweon Sik MIN, Stephen R. KRAUS, Roberta J. SECREST, Albert ELION-MBOUSSA and Lars VIKTRUP

    Version of Record online : 17 APR 2011, DOI: 10.1111/j.1757-5672.2011.00088.x

  19. You have free access to this content
    Combined Tadalafil and α-Blocker Therapy for Benign Prostatic Hyperplasia in Patients With Erectile Dysfunction: A Multicenter, Prospective Study

    Journal of Andrology

    Volume 33, Issue 3, May-June 2012, Pages: 397–403, Joo Yong Lee, Sung Yul Park, Tae Yoong Jeong, Hong Sang Moon, Yong Tae Kim, Tag Keun Yoo, Hong Yong Choi, Hae Young Park and Dr Seung Wook Lee

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.111.013185

  20. You have free access to this content
    Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment

    BJU International

    Volume 105, Issue 4, February 2010, Pages: 502–507, Claus G. Roehrborn, Jed C. Kaminetsky, Stephen M. Auerbach, Rafael Martínez Montelongo, Albert Elion-Mboussa and Lars Viktrup

    Version of Record online : 3 SEP 2009, DOI: 10.1111/j.1464-410X.2009.08822.x